This paper is in the following e-collection/theme issue:

JMIR Theme Issue: COVID-19 Special Issue (2461) Theme Issue: Novel Coronavirus (COVID-19) Outbreak Rapid Reports (1520) Outbreak and Pandemic Preparedness and Management (1743) Innovations in Clinical Trials and Research Data Management (84) Teleoncology (21) Innovations and Technology in Cancer Care (431)

Published on in Vol 23, No 3 (2021): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/26799, first published .
Minimizing the Impact of the COVID-19 Epidemic on Oncology Clinical Trials: Retrospective Study of Beijing Cancer Hospital

Minimizing the Impact of the COVID-19 Epidemic on Oncology Clinical Trials: Retrospective Study of Beijing Cancer Hospital

Minimizing the Impact of the COVID-19 Epidemic on Oncology Clinical Trials: Retrospective Study of Beijing Cancer Hospital

Authors of this article:

Zhiying Fu1 Author Orcid Image ;   Min Jiang1 Author Orcid Image ;   Kun Wang1 Author Orcid Image ;   Jian Li1 Author Orcid Image
Article Authors Cited by (5) Tweetations (3) Metrics

Zhiying Fu   1 * , MPH ;   Min Jiang   1 * , M.Pharm ;   Kun Wang   1 , MD ;   Jian Li   1 , MD

1 Beijing Institute for Cancer Research, Beijing Cancer Hospital, Beijing, China

*these authors contributed equally

Corresponding Author:

  • Jian Li, MD
  • Beijing Institute for Cancer Research
  • Beijing Cancer Hospital
  • No 52 Fucheng Road
  • Haidian District
  • Beijing
  • China
  • Phone: 86 1088196949
  • Email: LIJIAN8409@126.com